GSK4112 from Cayman Chemical

Supplier Page

Supplier Page from
Cayman Chemical for
GSK4112

Request Info

Description

A synthetic agonist for REV-ERBα (EC50 = 0.4 µM) that mimics the action of heme; at 10 µM inhibits the expression of the circadian target gene bmal1 and reduces glucose output by 30% in mouse primary hepatocytes by repressing the expression of several gluconeogenic genes